Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Apr 15;209(8):1039-1040.
doi: 10.1164/rccm.202311-2199LE.

Reply to Dournes and Benlala: Hierarchical Computed Tomography Scoring Systems Cannot Discriminate Between Reversible Bronchiectasis and Mucus Plugs

Paul McNally  1   2 , Jane Davies  3   4 , Pierluigi Ciet  5 , Harm Tiddens  6   7
Affiliations
Comment

Reply to Dournes and Benlala: Hierarchical Computed Tomography Scoring Systems Cannot Discriminate Between Reversible Bronchiectasis and Mucus Plugs

Paul McNally et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. McNally P, Lester K, Stone G, Elnazir B, Williamson M, Cox D, et al. RECOVER Study Group Improvement in lung clearance index and chest computed tomography scores with elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis aged 12 years and older: the RECOVER trial. Am J Respir Crit Care Med . 2023;208:917–929. - PubMed
    1. Tiddens HAWM, Andrinopoulou ER, McIntosh J, Elborn JS, Kerem E, Bouma N, et al. Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: lessons learned from the first ataluren phase 3 study. PLoS One . 2020;15:e0240898. - PMC - PubMed
    1. McNally P, Linnane B, Williamson M, Elnazir B, Short C, Saunders C, et al. The clinical impact of lumacaftor-ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting. Respir Res . 2023;24:199. - PMC - PubMed
    1. Lv Q, Gallardo-Estrella L, Andrinopoulou ER, Chen Y, Charbonnier JP, Sandvik RM, et al. Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis. Thorax . 2023;79:13–22. - PMC - PubMed
    1. Chen Y, Lv Q, Andrinopoulou ER, Gallardo-Estrella L, Charbonnier JP, Caudri D, et al. on behalf the SHIP-CT study group Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial. J Cyst Fibros . 2023;22:916–925. - PubMed

LinkOut - more resources